← All companies

APGE

Apogee Therapeutics, Inc.

APGE Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$134.11

-0.19 -0.14%

Key statistics

from XBRL data in SEC filings

Market cap

$9.34B

Revenue (TTM)

—

Net income (TTM)

-$275M

EPS (TTM)

$-4.33

P/E ratio

—

Dividend yield

—

Free cash flow

-$233M

Cash

$452M

Total assets

$1.29B

Gross margin

—

52-week range

$34.34 – $134.46

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Shareholder vote results; Regulation FD disclosure; Other events Jun 22, 2026 8-K Entered a material agreement Jun 22, 2026 8-K Shareholder vote results Jun 12, 2026 8-K Entered a material agreement; Regulation FD disclosure May 27, 2026 8-K Regulation FD disclosure; Other events May 27, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Director or officer change Apr 24, 2026 8-K Entered a material agreement Mar 25, 2026 8-K Regulation FD disclosure; Other events Mar 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Mar 2, 2026 8-K Regulation FD disclosure; Other events Jan 6, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 10, 2025 8-K Entered a material agreement; Other events Oct 10, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Regulation FD disclosure; Other events Jul 7, 2025 8-K Shareholder vote results Jun 23, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events May 12, 2025 8-K Entered a material agreement Mar 11, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Regulation FD disclosure; Other events Feb 3, 2025 8-K Regulation FD disclosure; Other events Dec 10, 2024 8-K Regulation FD disclosure; Other events Dec 2, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Regulation FD disclosure Oct 24, 2024 8-K Regulation FD disclosure; Other events Aug 19, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release); Other events Aug 12, 2024 8-K Shareholder vote results Jun 7, 2024 8-K Director or officer change; Regulation FD disclosure May 28, 2024 8-K Regulation FD disclosure May 15, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Regulation FD disclosure Mar 25, 2024